Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rxsight Inc RXST

Healthcare Medical Devices
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL... see more

Recent & Breaking News (NDAQ:RXST)

RxSight Reports Second Quarter 2021 Financial Results

GlobeNewswire September 9, 2021

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

GlobeNewswire September 1, 2021

RxSight to Participate in the Wells Fargo Healthcare Conference

GlobeNewswire August 31, 2021

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021 

GlobeNewswire August 24, 2021

RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales

GlobeNewswire August 17, 2021

RxSight Announces Appointments to its Board of Directors

GlobeNewswire August 10, 2021

RxSight, Inc. Announces Closing of Initial Public Offering and Partial Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire August 4, 2021

RxSight, Inc. Announces Pricing of Initial Public Offering

GlobeNewswire July 29, 2021